AI, Proteomics, and Advanced Analytics for Drug Development

28 Jan 2026
Proteogenomics & Translational Omics Stage
  • Showcase the use of AI and machine learning to accelerate clinical research through disease understanding, patient stratification biomarker discovery and improved trial design.  

  • Explore how proteomics, alongside genomics, imaging,  is integrated in clinical data to uncover novel disease mechanisms and therapeutic targets.  

  • Emphasize aligning scientific innovation with business needs to deliver actionable insights, foster strategic collaborations, and support data-informed decision-making across drug development. 

Speakers
Maria Dermit
Maria Dermit, Senior Research Scientist - Novo Nordisk